Announcement of Resolutions of the 29th Meeting of the Fifth Board of Directors

Securities code: 603716 Securities abbreviation: Saili Medical Announcement number: 2026-047

Thalys Medical Technology Group Co., Ltd.

The company's board of directors and all directors guarantee that the contents of this announcement do not contain any false records, misleading statements or major omissions, and assume legal responsibility for the authenticity, accuracy and completeness of its contents.

Important content reminder:

 All directors attended the board meeting in person;

 No director voted against/abstained from voting on this board meeting;

 All resolutions of this board meeting have been approved.

1. Convening of board of directors meetings

Thalys Medical Technology Group Co., Ltd. (hereinafter referred to as the "Company") sent the notice of the 29th meeting of the fifth board of directors by email on June 3, 2026. The meeting was held on June 8, 2026 in the conference room C of Building A of the company through a combination of on-site and communication methods. Nine directors should be present at this meeting, but actually 9 were present. The meeting was presided over by Mr. Wen Wei, the chairman of the board, and all senior managers of the company attended the meeting.

This board of directors went through appropriate notification procedures. The convening, holding and voting procedures of the meeting complied with the provisions of the Company Law and other relevant laws and regulations and the Articles of Association. The meeting and the resolutions passed were legal and valid.

2. Review status of board of directors meeting

This meeting reviewed and passed the following proposals:

(1) Consideration and approval of the "Proposal on the Termination of Raised Investment Projects and the Permanent Replenishment of Liquidity with Remaining Raised Funds"

For details, please refer to the "Announcement on the Termination of Fund-raising Projects and the Permanent Replenishment of Liquidity with Remaining Funds Raised" (Announcement Number: 2026-048) published on the website of the Shanghai Stock Exchange (www.sse.com.cn).

Voting results: There were a total of 9 valid votes, including 9 votes in favor, 0 votes against, and 0 abstentions.

This proposal still needs to be submitted to the company's shareholders' meeting for review.

(2) Consideration and approval of the “Proposal on Proposing to Convene the Second Extraordinary Shareholders’ Meeting in 2026”

The company plans to hold the second extraordinary shareholders meeting in 2026 at 14:00 pm on June 24, 2026, in the conference room A of Building A of the company. For details, please refer to the "Notice on Convening the Second Extraordinary Shareholders' Meeting in 2026" (announcement number: 2026-049) published on the website of the Shanghai Stock Exchange (www.sse.com.cn). The voting results: a total of 9 valid votes, including 9 votes in favor, 0 votes against, and 0 abstentions.

Announcement is hereby made.

The Board of Directors of Thalys Medical Technology Group Co., Ltd.

June 9, 2026